Structural and Biophysical Analysis of BST-2/tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Nov 19

PMID 21084286

Citations 48

Authors

Melissa Swiecki

Suzanne M Scheaffer

Marc Allaire

Daved H Fremont

Marco Colonna

Tom J Brett

Affiliations

Soon will be listed here.

Abstract

BST-2/tetherin is a host antiviral molecule that functions to potently inhibit the release of enveloped viruses from infected cells. In return, viruses have evolved antagonists to this activity. BST-2 traps budding virions by using two separate membrane-anchoring regions that simultaneously incorporate into the host and viral membranes. Here, we detailed the structural and biophysical properties of the full-length BST-2 ectodomain, which spans the two membrane anchors. The 1.6-Å crystal structure of the complete mouse BST-2 ectodomain reveals an ∼145-Å parallel dimer in an extended α-helix conformation that predominantly forms a coiled coil bridged by three intermolecular disulfides that are required for stability. Sequence analysis in the context of the structure revealed an evolutionarily conserved design that destabilizes the coiled coil, resulting in a labile superstructure, as evidenced by solution x-ray scattering displaying bent conformations spanning 150 and 180 Å for the mouse and human BST-2 ectodomains, respectively. Additionally, crystal packing analysis revealed possible curvature-sensing tetrameric structures that may aid in proper placement of BST-2 during the genesis of viral progeny. Overall, this extended coiled-coil structure with inherent plasticity is undoubtedly necessary to accommodate the dynamics of viral budding while ensuring separation of the anchors.

Citing Articles

Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein.

Marougka K, Judith D, Jaouen T, Blouquit-Laye S, Cosentino G, Berlioz-Torrent C PLoS Pathog. 2024; 20(11):e1012687.

PMID: 39561185 PMC: 11614281. DOI: 10.1371/journal.ppat.1012687.

Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).

Yu H, Bian Q, Wang X, Wang X, Lai L, Wu Z Oncol Rep. 2024; 51(3).

PMID: 38240088 PMC: 10828922. DOI: 10.3892/or.2024.8704.

Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists.

Hagelauer E, Lotke R, Kmiec D, Hu D, Hohner M, Stopper S Viruses. 2023; 15(12).

PMID: 38140605 PMC: 10747847. DOI: 10.3390/v15122364.

A CRISPR-Cas Cure for HIV/AIDS.

Hussein M, Molina M, Berkhout B, Herrera-Carrillo E Int J Mol Sci. 2023; 24(2).

PMID: 36675077 PMC: 9863116. DOI: 10.3390/ijms24021563.

Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1.

Zhao Y, Zhao K, Wang S, Du J Front Cell Infect Microbiol. 2022; 12:979091.

PMID: 36176574 PMC: 9513188. DOI: 10.3389/fcimb.2022.979091.

References

Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y . HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem. 2009; 284(50):35060-72. PMC: 2787367. DOI: 10.1074/jbc.M109.058305. View

Hoover D, Lubkowski J . DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 2002; 30(10):e43. PMC: 115297. DOI: 10.1093/nar/30.10.e43. View

Kaletsky R, Francica J, Agrawal-Gamse C, Bates P . Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A. 2009; 106(8):2886-91. PMC: 2650360. DOI: 10.1073/pnas.0811014106. View

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

Mertens H, Svergun D . Structural characterization of proteins and complexes using small-angle X-ray solution scattering. J Struct Biol. 2010; 172(1):128-41. DOI: 10.1016/j.jsb.2010.06.012. View

Burkhard P, Kammerer R, Steinmetz M, Bourenkov G, Aebi U . The coiled-coil trigger site of the rod domain of cortexillin I unveils a distinct network of interhelical and intrahelical salt bridges. Structure. 2000; 8(3):223-30. DOI: 10.1016/s0969-2126(00)00100-3. View

Evans D, Serra-Moreno R, Singh R, Guatelli J . BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 2010; 18(9):388-96. PMC: 2956607. DOI: 10.1016/j.tim.2010.06.010. View

Neil S, Zang T, Bieniasz P . Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008; 451(7177):425-30. DOI: 10.1038/nature06553. View

Blasius A, Giurisato E, Cella M, Schreiber R, Shaw A, Colonna M . Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol. 2006; 177(5):3260-5. DOI: 10.4049/jimmunol.177.5.3260. View

10.

Radoshitzky S, Dong L, Chi X, Clester J, Retterer C, Spurgers K . Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol. 2010; 84(20):10569-80. PMC: 2950602. DOI: 10.1128/JVI.00103-10. View

11.

Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J . Inhibition of Lassa and Marburg virus production by tetherin. J Virol. 2008; 83(5):2382-5. PMC: 2643706. DOI: 10.1128/JVI.01607-08. View

12.

Hammonds J, Wang J, Yi H, Spearman P . Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog. 2010; 6(2):e1000749. PMC: 2816691. DOI: 10.1371/journal.ppat.1000749. View

13.

Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G . Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic. 2003; 4(10):694-709. DOI: 10.1034/j.1600-0854.2003.00129.x. View

14.

Sadler A, Williams B . Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008; 8(7):559-68. PMC: 2522268. DOI: 10.1038/nri2314. View

15.

Van Damme N, Goff D, Katsura C, Jorgenson R, Mitchell R, Johnson M . The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008; 3(4):245-52. PMC: 2474773. DOI: 10.1016/j.chom.2008.03.001. View

16.

Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler O . Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol. 2010; 84(21):11374-84. PMC: 2953199. DOI: 10.1128/JVI.01067-10. View

17.

Hinz A, Miguet N, Natrajan G, Usami Y, Yamanaka H, Renesto P . Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe. 2010; 7(4):314-323. PMC: 2859121. DOI: 10.1016/j.chom.2010.03.005. View

18.

Douglas J, Gustin J, Viswanathan K, Mansouri M, Moses A, Fruh K . The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 2010; 6(5):e1000913. PMC: 2869331. DOI: 10.1371/journal.ppat.1000913. View

19.

Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana I . Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009; 5(5):e1000429. PMC: 2673686. DOI: 10.1371/journal.ppat.1000429. View

20.

McNatt M, Zang T, Hatziioannou T, Bartlett M, Fofana I, Johnson W . Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 2009; 5(2):e1000300. PMC: 2633611. DOI: 10.1371/journal.ppat.1000300. View